Carboplatin Dosing in Children: Calculation by Different Formulae

被引:0
|
作者
Wuerthwein, Gudrun [2 ]
Krefeld, Barbara [1 ]
Gerss, Joachim [3 ]
Boos, Joachim [1 ]
机构
[1] Univ Klinikum Munster, Klin & Poliklin Kinderheilkunde Padiatr Hamatol O, D-48129 Munster, Germany
[2] ZKS, Freiburg, Germany
[3] Univ Klinikum Munster, Abt Med Informat & Biomath, Munster, Germany
来源
ONKOLOGIE | 2011年 / 34卷 / 1-2期
关键词
Carboplatin; Dose calculation; Children; GLOMERULAR-FILTRATION-RATE; BODY-SURFACE AREA; SERUM CREATININE; POPULATION PHARMACOKINETICS; PLASMA CREATININE; RENAL-FUNCTION; SOLID TUMORS; PHASE-I; WEIGHT; HEIGHT;
D O I
10.1159/000323369
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Carboplatin dosing in children is based on renal function and there exists a wealth of formulae available for calculating the body surface area (BSA), the glomerular filtration rate (GFR), and the carboplatin dose. Patients and Methods: A fictitious group of children with different ages and body builds was 'constructed'. For comparison of formulae, bias and precision were assessed. Results: BSA calculations according to DuBois-DuBois, Gehan-George, Mosteller, and Boyd showed good agreement. GFR calculations according to the weight-based Cole formula and the Leger formula gave comparable results. Regarding GFR in young children, the weight- and creatinine-based Cole and the Schwartz formula showed clear differences. Again, carboplatin dose calculations according to Marina, Newell, and Chatelut are comparable. Moreover, the precision of the creatinine measurement has a clear influence on the result of the dose calculation. Conclusions: The choice of the GFR formula is more important for the carboplatin dose calculation compared to the BSA or dose equation. GFR calculations in children show marked, age-dependent variations. A sequence of multiple calculation steps (especially for the Schwartz and Marina formulae) may lead to considerable uncertainty and proneness to error in the clinical routine. In high-risk patients, GFR should be measured precisely and complemented by therapeutic drug monitoring.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 50 条
  • [11] Investigating current practices in renal function measurement and carboplatin dosing in children with cancer - a UK perspective
    Roberts, Eve
    Mogg, Jasper A. W.
    Barnfield, Mark
    Veal, Gareth J.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2020, 37 (03) : 235 - 244
  • [12] Weekly dosing of carboplatin increases risk of allergy in children
    Yu, DY
    Dahl, GVH
    Shames, RS
    Fisher, PG
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (06) : 349 - 352
  • [13] Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma
    Picton, S. V.
    Keeble, J.
    Holden, V.
    Errington, J.
    Boddy, A. V.
    Veal, G. J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (04) : 749 - 752
  • [14] Comparative study of different formulae for prediction of best fit endotracheal tube size in children
    Subramani, Satheeskumar
    Pandey, Maitree
    Gupta, Anshu
    Kohli, Pramod
    Varshney, Preeti Goyal
    AIN SHAMS JOURNAL OF ANESTHESIOLOGY, 2023, 15 (01)
  • [15] Comparative study of different formulae for prediction of best fit endotracheal tube size in children
    Satheeskumar Subramani
    Maitree Pandey
    Anshu Gupta
    Pramod Kohli
    Preeti Goyal Varshney
    Ain-Shams Journal of Anesthesiology, 15
  • [16] Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer
    Shimokata, Tomoya
    Ando, Yuichi
    Yasuda, Yoshinari
    Hamada, Akinobu
    Kawada, Kenji
    Saito, Hideyuki
    Matsuo, Seiichi
    Kondo, Masashi
    Imaizumi, Kazuyoshi
    Hasegawa, Yoshinori
    CANCER SCIENCE, 2010, 101 (12): : 2601 - 2605
  • [17] Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function
    Adamson, Peter C.
    Veal, Gareth J.
    Womer, Richard B.
    Meany, Holly J.
    Bernhardt, M. Brooke
    Frazier, A. Lindsay
    Balis, Frank M.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (06)
  • [18] Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors
    Kaag, Dieter
    LUNG CANCER, 2013, 79 (01) : 54 - 58
  • [19] Vancomycin Dosing in Children and Young Adults: Back to the Drawing Board
    Camaione, Lauren
    Elliott, Kimberly
    Mitchell-Van Steele, Amy
    Lomaestro, Ben
    Pai, Manjunath P.
    PHARMACOTHERAPY, 2013, 33 (12): : 1278 - 1287
  • [20] Dosing of carboplatin in a patient with amputated legs: A case report
    van Gorp, F.
    van Rens, M. Th M.
    Kuck, E. M.
    Rozemeijer, R.
    Huitema, A. D. R.
    Brouwers, E. E. M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (06) : 473 - 475